Screen Shot 2017-03-29 at 11.59.11 AM

PrEP Toolkit: Accessing PrEP

The Centers for Disease Control and Prevention (CDC) has estimated that approximately 1.2 million individuals in the United States (US) have a substantial risk of contracting human immunodeficiency virus (HIV) and could benefit from pre-exposure prophylaxis (PrEP) as an HIV prevention strategy. Given the high number of individuals who could potentially benefit from this strategy, being prepared to help patients navigate the costs associated with PrEP—which include medication and doctor/clinic visits—can make PrEP implementation more manageable.

Please click on the following link to download PrEP Toolkit: Accessing PrEP.